Exploratory research for the autophagy-related efficacy of urolithin in healthy Japanese women: a randomized, dose-controlled, open-label, parallel-group comparison study - Exploratory research for the autophagy-related efficacy of urolithin in healthy Japanese women

ORTHOMEDICO Inc.0 个研究点目标入组 62 人开始时间: 2022年7月22日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, hypotension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 5. Subjects who are currently taking medications (including herbal medicines) and supplements 6. Subjects who use herb or supplements with antihypertensive effects, or use antihypertensive drugs such as angiotensin-converting enzyme inhibitor 7. Subjects who use anticoagulant agent 8. Subjects who are allergic to medicines and/or the test food related products 9. Subjects who are pregnant, lactation, or planning to become pregnant during this trial 10. Subjects who suffer from COVID-19 11. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 12. Subjects who are judged as ineligible to participate in this study by the physician

发起方